EUVIMEDEUVIMED entdecken
Crossref

Radiotherapy Resources in Central Asia: An International Atomic Energy Agency Update

Sondos AlKhatib iD, Kamal Akbarov iD, Varsha Hande iD, Olivera Ciraj-Bjelac iD, May Abdel-Wahab

JCO Global Oncology · 2025

DOI: 10.1200/go-25-00271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Sondos AlKhatib und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Henry Ford Cancer Institute, Detroit, MI. Hauptthemen laut MEDLINE: Health Resources, Radiotherapy, Neoplasms, Radiation Oncology. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Radiation therapy is crucial in cancer treatment. However, low- and middle-income countries (LMICs), including Central Asia (Kazakhstan, Uzbekistan, Turkmenistan, Kyrgyzstan, Tajikistan), face increasing challenges because of limited radiation oncology resources, compounded by diverse health care systems and vast geography. METHODS A longitudinal, registry-based review analyzed the state of radiation oncology resources in Central Asia to assess current conditions and future needs, considering projected regional growth. Data were sourced from the Directory of Radiotherapy Centres (DIRAC) and GLOBOCAN 2020. A simple linear regression evaluated the relationship between machine capacity rate and Gross National Income (GNI) per capita. RESULTS As of 2022, the region has 75 megavoltage machines and 35 brachytherapy (BT) units, with all but two being high-dose rate BT. The number of megavoltage units per million population varies, ranging from 0.1 to 0.2 in Tajikistan, Kyrgyzstan, and Uzbekistan, and it is 2.3 in Kazakhstan. A significant correlation between GNI per capita and machine capacity was found (R 2 = 0.89, P = .014), indicating that higher GNI correlates with increased machine capacity. By 2030, a minimum of 115 megavoltage machines will be needed to meet demand, but only 75 are available as of 2022. CONCLUSION While progress has been made, there remain significant challenges to ensuring equitable access to radiation therapy across Central Asia, underscoring the need for additional resources to meet growing demands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health ResourcesRadiotherapyNeoplasmsRadiation OncologyHumansAsia, CentralInternational AgenciesDeveloping CountriesNuclear Energy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Henry Ford Cancer Institute, Detroit, MI.
  • Department of Radiation Oncology, National Centre of Oncology, Baku, Azerbaijan.
  • Department of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Division of Human Health, Department of Nuclear Science and Application, International Atomic Energy Agency IAEA, Vienna, Austria.

ORCID-Profile: Sondos AlKhatib, Kamal Akbarov, Varsha Hande, Olivera Ciraj-Bjelac

Zitieren

APA

AlKhatib, S., Akbarov, K., Hande, V., Ciraj-Bjelac, O., & Abdel-Wahab, M. (2025). Radiotherapy Resources in Central Asia: An International Atomic Energy Agency Update. JCO Global Oncology. https://doi.org/10.1200/go-25-00271

Vancouver

AlKhatib S, Akbarov K, Hande V, Ciraj-Bjelac O, Abdel-Wahab M. Radiotherapy Resources in Central Asia: An International Atomic Energy Agency Update. JCO Global Oncology. 2025. doi:10.1200/go-25-00271

BibTeX
@article{AlKhatib2025,
  author = {AlKhatib, Sondos and Akbarov, Kamal and Hande, Varsha and Ciraj-Bjelac, Olivera and Abdel-Wahab, May},
  title = {Radiotherapy Resources in Central Asia: An International Atomic Energy Agency Update},
  journal = {JCO Global Oncology},
  year = {2025},
  doi = {10.1200/go-25-00271}
}
Kostenlos starten →